Cargando…
The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells
Although a large fraction of high-grade serous epithelial ovarian cancers (OCs) expresses Estrogen Receptor alpha (ERα), anti-estrogen-based therapies are still not widely used against these tumors due to a lack of sufficient evidence. The histone methyltransferase Disruptor of telomeric silencing-1...
Autores principales: | Salvati, Annamaria, Gigantino, Valerio, Nassa, Giovanni, Giurato, Giorgio, Alexandrova, Elena, Rizzo, Francesca, Tarallo, Roberta, Weisz, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895927/ https://www.ncbi.nlm.nih.gov/pubmed/31689915 http://dx.doi.org/10.3390/cancers11111720 |
Ejemplares similares
-
Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors
por: Alexandrova, Elena, et al.
Publicado: (2022) -
Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells
por: Nassa, Giovanni, et al.
Publicado: (2019) -
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer
por: Alexandrova, Elena, et al.
Publicado: (2022) -
The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei
por: Nassa, Giovanni, et al.
Publicado: (2019) -
Quantitative mapping of RNA-mediated nuclear estrogen receptor β interactome in human breast cancer cells
por: Giurato, Giorgio, et al.
Publicado: (2018)